Innovation & Tech
CoreWeave's stock and bonds tumble as investors question the financing behind AI data center expansion. Nvidia faces renewed scrutiny over its financial ties to the cloud provider, while rising borrowing costs pressure the broader AI sector.
Earnings
UnitedHealth beats third-quarter earnings expectations and raises its 2026 outlook as medical costs ease and Optum profitability improves. Investors remain focused on shrinking Medicare enrollment and the sustainability of its recovery.
Innovation & Tech
Docusign expands its Salesforce partnership, embedding AI-powered contract management into Agentforce and Slack. The integration strengthens its Intelligent Agreement Management strategy as enterprise adoption accelerates.
Earnings
Asset Inflows Drive BlackRock and Morgan Stanley Growth
Earnings
Bank of America shares plunged after a $1.2 billion regulatory penalty and weaker trading revenue contributed to a third-quarter earnings miss. Strong lending income offered support, but compliance costs and rising bond losses added pressure.
Macro
September inflation accelerated to 3.7% as energy and shelter costs climbed. Treasury yields surged, stock futures retreated, and investors reassessed the likelihood of another Federal Reserve interest rate hike.
Macro
Oil prices remain elevated as Middle East supply threats, a controversial Russian diesel agreement and limited U.S. emergency reserves complicate efforts to lower fuel costs ahead of a closely watched inflation report.
Chinese chip competition rattled semiconductor stocks, major banks reported mixed results, and the Magnificent Seven continued supporting the S&P 500.
Sector
A memory-chip breakthrough announced by China's CXMT sparked a global semiconductor sell-off, sending Micron, SK Hynix and Samsung lower. Investors are reassessing competition, memory pricing power and crowded AI-related positions.
Price Action
BTIG Research warns that the Magnificent Seven remain a critical source of support for the S&P 500 as software gains ground on semiconductors and unusual divergences emerge across homebuilders, REITs, utilities and refiners.
Earnings
Johnson & Johnson shares fell nearly 6% despite stronger-than-expected earnings and raised guidance. Slowing MedTech growth, a $5.5 billion talc litigation charge and plans to separate its orthopedics business drew investor attention.
Earnings
JPMorgan Chase reported higher third-quarter profits but missed Wall Street expectations as securities losses and rising expenses weighed on results. Strong lending, trading and wealth management revenue supported shares, while the bank raised its interest income outlook.